BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kahn A, Shaheen NJ, Iyer PG. Approach to the Post-Ablation Barrett's Esophagus Patient. Am J Gastroenterol 2020;115:823-31. [PMID: 31899706 DOI: 10.14309/ajg.0000000000000514] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Wong CK, Joseph K, Turner SR. Treatment Options for Patients With Persistent Disease After Initial Endotherapy for Esophageal Neoplasia. Foregut 2022;2:123-131. [DOI: 10.1177/26345161221115360] [Reference Citation Analysis]
2 Shaheen NJ, Falk GW, Iyer PG, Souza RF, Yadlapati RH, Sauer BG, Wani S. Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline. Am J Gastroenterol 2022;117:559-87. [PMID: 35354777 DOI: 10.14309/ajg.0000000000001680] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 13.0] [Reference Citation Analysis]
3 Kolb JM, Wani S. Endoscopic Management of Barrett's Esophagus. Dig Dis Sci 2022. [PMID: 35226224 DOI: 10.1007/s10620-022-07395-x] [Reference Citation Analysis]
4 Zhang LY, Kalloo AN, Ngamruengphong S. Therapeutic Endoscopy and the Esophagus: State of the Art and Future Directions. Gastroenterol Clin North Am 2021;50:935-58. [PMID: 34717880 DOI: 10.1016/j.gtc.2021.08.007] [Reference Citation Analysis]
5 Farina DA, Condon A, Komanduri S, Muthusamy VR. A Practical Approach to Refractory and Recurrent Barrett's Esophagus. Gastrointest Endosc Clin N Am 2021;31:183-203. [PMID: 33213795 DOI: 10.1016/j.giec.2020.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Bowman CJ, Zhang R, Balitzer D, Wang D, Rabinovitch PS, Kővári BP, Mattis AN, Kakar S, Lauwers GY, Choi WT. Persistent or recurrent Barrett's neoplasia after an endoscopic therapy session is associated with DNA content abnormality and can be detected by DNA flow cytometric analysis of paraffin-embedded tissue. Mod Pathol 2021. [PMID: 34108638 DOI: 10.1038/s41379-021-00832-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Mittal SK, Baboli KM, Bremner RM. Reflux Control After Barrett’s Esophagus Ablation. Foregut 2021;1:78-85. [DOI: 10.1177/2634516121997233] [Reference Citation Analysis]
8 Solfisburg QS, Sami SS, Gabre J, Soroush A, Dhaliwal L, Beveridge C, Jin Z, Poneros JM, Falk GW, Ginsberg GG, Wang KK, Lightdale CJ, Iyer PG, Abrams JA. Clinical significance of recurrent gastroesophageal junction intestinal metaplasia after endoscopic eradication of Barrett's esophagus. Gastrointest Endosc 2021;93:1250-1257.e3. [PMID: 33144238 DOI: 10.1016/j.gie.2020.10.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
9 Dam AN, Klapman J. A narrative review of Barrett's esophagus in 2020, molecular and clinical update.Ann Transl Med. 2020;8:1107. [PMID: 33145326 DOI: 10.21037/atm-20-4406] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]